Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/CHEBI_4670
http://purl.obolibrary.org/obo/CHEBI_4670
|
|---|---|
| Preferred Name | dobutamine |
| Synonyms |
DOBUTAMINE
4-{2-[3-(4-Hydroxy-phenyl)-1-methyl-propylamino]-ethyl}-benzene-1,2-diol
DL-dobutamine
3,4-dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-beta-phenylethylamine
dobutamine
C18H23NO3
dobutaminum
4-(2-{[4-(4-hydroxyphenyl)butan-2-yl]amino}ethyl)benzene-1,2-diol
(+-)-4-(2-((3-(p-hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol
racemic-dobutamine
Dobutamine
rac-dobutamine
dobutamina
See more
See less
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | dobutamine
|
|---|---|
| label | dobutamine
|
| ATCCode | C01CA07
|
| Definition | 4-(3-Aminobutyl)phenol in which one of the hydrogens attached to the nitrogen is substituted by a 2-(3,4-dihydroxyphenyl)ethyl group. A beta1-adrenergic receptor agonist that has cardiac stimulant action without evoking vasoconstriction or tachycardia, it is used as the hydrochloride to increase the contractility of the heart in the management of acute heart failure.
|
| altId |
CHEBI:554519
CHEBI:184505
|
| has effect |
See more
See less
|
| has pharmacological target | |
| activates | |
| type | |
| has role | |
| InChIKey | InChIKey=JRWZLRBJNMZMFE-UHFFFAOYSA-N
|
| is metabolised by | |
| AHFScode | 12:12.08.08
|
| Synonym |
DOBUTAMINE
4-{2-[3-(4-Hydroxy-phenyl)-1-methyl-propylamino]-ethyl}-benzene-1,2-diol
DL-dobutamine
3,4-dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-beta-phenylethylamine
dobutamine
C18H23NO3
dobutaminum
4-(2-{[4-(4-hydroxyphenyl)butan-2-yl]amino}ethyl)benzene-1,2-diol
(+-)-4-(2-((3-(p-hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol
racemic-dobutamine
Dobutamine
rac-dobutamine
dobutamina
See more
See less
|
| xref |
ChemSpider:33786
RxList:http://www.rxlist.com/cgi/generic3/dobutamine.htm
Patent:DE2317710
National Drug Code Directory:55390-560-90
Guide To Pharmacology:535
ChEBI:4670
CiteXplore:11950781
DrugBank:DB00841
CASRN:34368-04-2
Beilstein:2946389
Drugs Product Database (DPD):2242010
BindingDB:50028971
IUPHAR:535
Drugs.com:http://www.drugs.com/cdi/dobutamine.html
PharmGKB:PA449381
Wikipedia:http://en.wikipedia.org/wiki/Dobutamine
Wikipedia:Dobutamine
CiteXplore:22537238
KEGG DRUG:D03879
PubChem Compound:36811
CiteXplore:11280019
CiteXplore:18323735
PubChem Substance:46505241
Patent:US3987200
Reaxys:2946389
KEGG COMPOUND:C06967
See more
See less
|
| CASRN | 34368-04-2
|
| prefixIRI | obo2:CHEBI_4670
|
| SMILES |
CC(CCC1=CC=C(O)C=C1)NCCC1=CC(O)=C(O)C=C1
CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1
|
| may interact with |
See more
See less
|
| DBname | dobutamine
|
| InChI | InChI=1S/C18H23NO3/c1-13(2-3-14-4-7-16(20)8-5-14)19-11-10-15-6-9-17(21)18(22)12-15/h4-9,12-13,19-22H,2-3,10-11H2,1H3
|
| DBBrand |
dobutamine [usan:ban:inn]
dobutamine hcl
dobutaminum [inn-latin]
racemic-dobutamine
dobutamina [inn-spanish]
dobutamine hcl in dextrose 5%
dobutamine hydrochloride
inotrex
dobutamine [usan]
dobutrex
See more
See less
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |